SS
ANIP icon

SBI Securities’s ANI Pharmaceuticals ANIP Stock Holding History

SBI Securities’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50
Closed -$3.95K – 4025
2025
Q4 		$3.95K Hold
50
– – ﹤0.01% 2111
2025
Q3 		$4.58K Sell
50
-1
-2% -$82 ﹤0.01% 2083
2025
Q2 		$3.33K Sell
51
-49
-49% -$3.19K ﹤0.01% 2177
2025
Q1 		$6.7K Buy
100
+50
+100% +$2.99K ﹤0.01% 1776
2024
Q4 		$2.76K Buy
+50
New +$2.87K ﹤0.01% 2169

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SBI Securities's ANIP Position: Q1 2026 in Review

SBI Securities sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 50 shares — an estimated $3.95K sold.

SBI Securities first reported a position in ANIP in Q4 2024 and held it in 5 quarters. The position peaked at $6.7K in Q1 2025. 281 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • SBI Securities reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • SBI Securities sold 50 ANI Pharmaceuticals shares in Q1 2026, an estimated $3.95K.
  • SBI Securities first reported a position in ANI Pharmaceuticals in Q4 2024 and held it in 5 quarters.
  • SBI Securities's ANI Pharmaceuticals position peaked at $6.7K in Q1 2025.
  • 281 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.